Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Lumos Pharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 2.39M | 2.44M | +46.8K (+2.0%) |
| Value | $7.90M | $8.05M | +$157.0K (+2.0%) |
New holders (1)
Institutions that held Lumos Pharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 3 | $10 | 0.00% |
Sold out (2)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Minerva Advisors LLC | 26,549 | $84.7K |
| Millennium Management LLC | 14,940 | $49.3K |